Recent Updates
Recently added Catalysts

Upcoming Catalyst

Drug Pipeline Intelligence

Clinical Trial Results

Inside Trades

Options Data

News Section

Hedge Funds

Ownership Trends

Competitive Position

LakeShore Biopharma Co., Ltd

35 indications, side-by-side phase, drug & LoA

$0.63

-0.16 (-20.62%)

C 46Pipeline Score Fair Value Biotech · Clinical
Market Cap
25.84 M
EPS
-
P/E Ratio
-
Value Trade
613.76 K
-26.24 %
Week
-20.64 %
1 Month
-32.58 %
3 Month
-71.24 %
6 Month
-99.34 %
5 Year
-99.34 %
All Time
Cash Data

  • Cash Position

    12.35 K

  • Monthly Burn

    12.35 K

  • Runway

    12,345 mo

Overview
Volume
942.22 K
52 Week Range
0.57 - 8.60
% held by Insiders
82.69 %
% held by Institutions
6.24 %
Enterprise Value
68.60 M
Total Shares
41.21 M
Short %
0.24 %
Float Shares
4.96 M
Company Description

locked

Upcoming Catalyst
Catalyst Drug/Treatment Stage Probability of Approval Description Drug Type Therapeutic Area Source
Phase 3 data readout example
Phase 3
—
-
-
Phase 3
—
-
-
Phase 3
—
-
-
Unlock Upcoming Catalyst data
Drug Pipeline Intelligence
C46
Pipeline Score
$23M
Pipeline Value
Fair Value
Valuation Signal
3
Drugs Scored
0.9x
rNPV / MCap
Top 63%
Micro Cap
(rank 336 of 905)
Percentile Rank
LakeShore Biopharma Co., Ltd carries a moderate pipeline score (46/100), with $5.8B risk-adjusted pipeline value, led by PIKA COVID-19 vaccine in Covid-19 Vaccine (Phase 2), across $51B in total addressable markets.
Showing 1 of 1 assets
DrugIndicationPhaseNCT IDPTRSrNPVStatusEnrollmentVelocityDesignCompletionML SignalLast Change
PIKA COVID-19 vaccine
Monoclonal antibody		Covid-19 VaccinePhase 2NCT0546341954% $5.6B COMPLETED 5,860 - -Apr 11, 2024 -Jul 23, 2024
Unlock Drug Pipeline Intelligence
LSB Clinical Trial Results & History
Drug Name Indications Phase Date Trial Results Summary Title Source
YSJATM rabies vaccine
rabies
Phase 3
2025-07-31
YSJATM rabies vaccine
rabies
Phase 3
2025-07-31
YSJATM rabies vaccine
rabies
Phase 3
2025-07-31
Unlock Clinical Trial Results data
Inside Trades
TREND
CORPORATE INSIDERS BOUGHT SHARES WORTH 1.8M IN THE LAST 3 MONTHS
YEARLY INSIDER TRANSACTIONS
Sector Avg.
INSIDERS
SOLDINSIDERS
BOUGHT
POSITIVE SENTIMENT Based on 22 Insiders Transactions
Unlock Inside Trades data
Show Data
Hedge Funds
TREND
HEDGE FUNDS INCREASED HOLDINGS BY 200.0K SHARES IN THE LAST QUARTER
Shares Held
2040.00B1530.00B1020.00B510.00B0
Q3
2024
Q4
2024
Q1
2025
Q2
2025
HEDGE FUNDS
SOLDHEDGE FUNDS
BOUGHT
POSITIVE SENTIMENT Based on 27 hedge funds in the last quarter
18 buying (3 new)·9 selling (1 exited)·2 unchanged
Fund Count
60%
Share Volume
25%
Conviction
15%
Hedge Funds invested in LSB
HedgeFund Name
( 3 )
% of Portfolio Current MV
-
Shares Owned
-
Activity
Avg Price $0

Example Capital Management

2.5 %
15.00 M
250.00 K

Example Capital Management

2.5 %
15.00 M
250.00 K

Example Capital Management

2.5 %
15.00 M
250.00 K
Unlock Hedge Funds table data
LakeShore Biopharma Co., Ltd (LSB) Analyst Ratings & Price Targets
Symbol
Firm
Rating
Action
Price Target
Upside
date
LSB
Example Securities
Buy
Initiated
$150.00
+25%
2026-01-15
LSB
Example Securities
Buy
Initiated
$150.00
+25%
2026-01-15
LSB
Example Securities
Buy
Initiated
$150.00
+25%
2026-01-15
Unlock Biotech Analyst Ratings data
LSB Stock Forecast & Analyst Consensus
BUY
Analyst Ratings
Buy65.0%
Hold25.0%
Sell10.0%
Price Target Trend
Average$24.00
Low$18.00
High$32.00
Unlock Price Target Trend
LSB Institutional Ownership Trends
Current Insider %
5.20%
—+0.00%
Current Institutional %
62.40%
—+0.00%
Total Ownership
67.60%
Insider + Institutional
Data Points
1
1 Ticker(s)
Option Chain Statistics
ExpirationVolumeOpen InterestImplied Volatility CallsImplied Volatility Puts
CallsPutsPut-Call RatioCallsPutsPut-Call RatioIVOiWaIvVWaIvIVOiWaIvVWaIv
Unlock Option Chain Statistics data
Option Chain
CallsStrikePuts
Last PriceVolumeOpen InterestLast PriceVolumeOpen Interest
No data available
Unlock Option Chain data
Unlock Options Chart data
Open interest
0 600K 1.2M 1.8M Avg OI 1.00 M Open Interest
0 1 2 3 1.1 Put-Call Ratio
Today's Open Interest
1.00 M
Put-Call Ratio
1.1
Put Open Interest
480.00 K
Call Open Interest
520.00 K
Open Interest Avg (30-day)
900,000
Today vs Open Interest Avg (30-day)
11.11%
Option Volume
0 450K 900K 1.4M Avg OV 750.00 K Option Volume
0 1 2 3 0.95 Put-Call Ratio
Today's Volume
750.00 K
Put-Call Ratio
0.95
Put Volume
360.00 K
Call Volume
390.00 K
Volume Avg (30-day)
800,000
Today vs Volume Avg (30-day)
-6.25%
Latest LakeShore Biopharma Co., Ltd (LSB) News & Alerts
-
Thursday, June 11, 2026
(%)
+ More

Demo Biotech Announces Positive Phase 3 Results

Competitive Position
How LSB ranks across every disease it competes in
No competitive intelligence available for LSB.